Diagnostic Medical (ALDMS) | Financial Analysis & Statements
Diagnostic Medical Systems S.A. | Small-cap | Healthcare
Diagnostic Medical Systems S.A. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
46.1M
Gross Profit
18.4M
39.92%
Operating Income
-1.3M
-2.87%
Net Income
-2.8M
-6.11%
EPS (Diluted)
-€0.14
Balance Sheet Metrics
Total Assets
53.9M
Total Liabilities
39.8M
Shareholders Equity
14.2M
Debt to Equity
2.81
Cash Flow Metrics
Operating Cash Flow
3.2M
Free Cash Flow
30.0K
Revenue & Profitability Trend
Diagnostic Medical Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 46.1M | 42.2M | 35.3M | 36.3M | 32.1M |
| Cost of Goods Sold | 27.7M | 26.3M | 21.4M | 22.9M | 19.4M |
| Gross Profit | 18.4M | 15.8M | 13.8M | 13.3M | 12.6M |
| Operating Expenses | 9.2M | 15.1M | 10.7M | 10.8M | 4.9M |
| Operating Income | -1.3M | -9.2M | -5.1M | -488.0K | -2.4M |
| Pre-tax Income | -2.6M | -9.8M | -6.6M | -2.6M | -4.2M |
| Income Tax | 205.0K | 2.0K | 20.0K | 0 | -1.0K |
| Net Income | -2.8M | -5.0M | -9.0M | -4.7M | -5.5M |
| EPS (Diluted) | -€0.14 | -€0.28 | -€0.42 | -€0.24 | -€0.33 |
Income Statement Trend
Diagnostic Medical Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 30.3M | 31.7M | 29.0M | 28.1M | 24.4M |
| Non-Current Assets | 23.6M | 19.5M | 24.9M | 25.0M | 21.4M |
| Total Assets | 53.9M | 51.1M | 53.9M | 53.0M | 45.8M |
| Liabilities | |||||
| Current Liabilities | 23.5M | 22.0M | 24.4M | 21.7M | 18.1M |
| Non-Current Liabilities | 16.3M | 15.4M | 11.3M | 10.9M | 10.6M |
| Total Liabilities | 39.8M | 37.4M | 35.7M | 32.6M | 28.6M |
| Equity | |||||
| Total Shareholders Equity | 14.2M | 13.7M | 18.2M | 20.4M | 17.2M |
Balance Sheet Composition
Diagnostic Medical Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -2.8M | -5.0M | -9.0M | -4.7M | -5.5M |
| Operating Cash Flow | 3.2M | -4.6M | -4.7M | -6.9M | -4.3M |
| Investing Activities | |||||
| Capital Expenditures | -3.5M | -2.6M | -4.5M | -2.0M | -3.1M |
| Investing Cash Flow | -2.9M | -1.5M | -5.7M | -2.7M | 4.6M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 627.0K | 3.5M | 3.1M | 6.2M | 1.0M |
| Free Cash Flow | 30.0K | -4.4M | -4.2M | -7.0M | -6.8M |
Cash Flow Trend
Diagnostic Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-8.64
Forward P/E
24.20
Price to Book
1.96
Price to Sales
0.50
PEG Ratio
0.17
Profitability Ratios
Profit Margin
-5.90%
Operating Margin
1.90%
Return on Equity
-20.20%
Return on Assets
-0.94%
Financial Health
Current Ratio
1.29
Debt to Equity
141.76
Beta
0.88
Per Share Data
EPS (TTM)
-€0.13
Book Value per Share
€0.62
Revenue per Share
€2.39
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| aldms | 24.2M | -8.64 | 1.96 | -20.20% | -5.90% | 141.76 |
| Eurobio Scientific | 253.4M | 64.74 | 1.42 | 2.26% | 2.58% | 5.46 |
| Affluent Medical | 53.3M | -3.55 | 1.73 | -48.69% | -275.50% | 0.54 |
| Carmat S.A | 24.8M | - | - | 100.52% | -336.56% | -1.13 |
| Median Technologies | 25.6M | -1.02 | - | 74.31% | -109.93% | -0.98 |
| Novacyt S.A | 34.9M | -0.82 | 0.72 | -57.28% | -212.73% | 24.81 |
Financial data is updated regularly. All figures are in the company's reporting currency.